Advertisement

Phaeochromocytoma

  • Anand Kumar Mishra
  • Kulranjan Singh
  • Pooja Ramakant
  • Amit Agarwal
Chapter

Abstract

Phaeochromocytomas (PCCs) are tumours that synthesize, store and secrete catecholamines and arise from chromaffin cells of adrenal medulla and extra-adrenal sympathetic ganglia cells. Embryologically, the paraganglia system originates from the neural crest cells, which can differentiate and migrate to form the adrenal medullary chromaffin cells, autonomic ganglion cells and extra-adrenal paraganglionic cells. These cells belong to the amine precursor uptake decarboxylase (APUD) cells. Phaeochromocytoma derives its name from phaios (dusky), chroma (colour) and cytoma (tumour). The term phaeochromocytoma was coined by Pick in 1912. Fränkel was first to report a phaeochromocytoma during autopsy in 1886. The first successful operations for phaeochromocytomas were first reported in 1926 by Cesar Roux in Lausanne, Switzerland, and C.H. Mayo in the United States; but in neither case was the diagnosis established before the operation.

Bibliography

  1. 1.
    Manger WM, Gifford RW. Pheochromocytoma. J Clin Hypertens. 2002;4:62–72.CrossRefGoogle Scholar
  2. 2.
    Manger WM. An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci. 2006;1073:1–20.CrossRefGoogle Scholar
  3. 3.
    Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92:4069–79.CrossRefGoogle Scholar
  4. 4.
    Thomas RM, Ruel E, Shantavasinkul PC, Corsino L. Endocrine hypertension: an overview on the current etiopathogenesis and management options. World J Hypertens. 2015;5(2):14–27.CrossRefGoogle Scholar
  5. 5.
    Lentschener C, Gaujoux S, Tesniere A, Dousset B. Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal? Eur J Endocrinol. 2011;165(3):365–73.CrossRefGoogle Scholar
  6. 6.
    Ramakrishna H. Pheochromocytoma resection: current concepts in anesthetic management. J Anaesthesiol Clin Pharmacol. 2015;31(3):317–23.CrossRefGoogle Scholar
  7. 7.
    Goldstein RE, O’Neill JA Jr, Holcomb GW 3rd, Morgan WM 3rd, Neblett WW 3rd, Oates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN, Scott HW Jr. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229(6):755–64; discussion 764–6CrossRefGoogle Scholar
  8. 8.
    Groeben H, Nottebaum BJ, Alesina PF, Traut A, Neumann HP, Walz MK. Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth. 2017;118(2):182–9.CrossRefGoogle Scholar
  9. 9.
    Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, de Herder WW, Kazemier G. Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab. 2010;95(2):678–85.CrossRefGoogle Scholar
  10. 10.
    Bravo E. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev. 1994;15(3):356–68.CrossRefGoogle Scholar
  11. 11.
    Pacak K, et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001;134(4):315–29.CrossRefGoogle Scholar
  12. 12.
    Manger WM, Gifford RW. Clinical and experimental pheochromocytoma. 2nd ed. Cambridge, MA: Blackwell Science; 1996.Google Scholar
  13. 13.
    Plouin PF, Degoulet P, Tugaye A, et al. Screening for phaeochromocytoma: in which hypertensive patients? A semilogical study of 2585 patients, including 11 with phaeochromcytoma. Nouv Press Med. 1981;10(11):869–72.Google Scholar
  14. 14.
    Brouwers FM, Lenders JW, Eisenhofer G, Pacak K. Pheochromocytoma as an endocrine emergency. Rev Endocr Metab Disord. 2003;4:121–8.CrossRefGoogle Scholar
  15. 15.
    Jafri M, Maher ER. The genetics of phaeochromocytoma: using clinical features to guide genetic testing. Eur J Endocrinol. 2012;166:151–8.CrossRefGoogle Scholar
  16. 16.
    Havekes B, King K, Lai EW, Romijn JA, Corssmit EP, Pacak K. New imaging approaches to pheochromocytomas and paragangliomas. Clin Endocrinol. 2010;72:137–45.CrossRefGoogle Scholar
  17. 17.
    Brandao LF, Autorino R, Laydner H, Haber G-P, Ouzaid I, Sio MD, Perdona S, Stein RJ, Porpiglia F, Kaouk JH. Robotic versus laparoscopic adrenalectomy: a systematic review and meta-analysis. Eur Urol. 2014;65:1154–61.CrossRefGoogle Scholar
  18. 18.
    Golden SH, Robinson KA, Saldanha I, et al. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009;94:1853–78.CrossRefGoogle Scholar
  19. 19.
    Lenders J, Eisenhofer G, Mannelli M, Pacak K. Phaeochromo cytoma. Lancet. 2005;366:665–75.CrossRefGoogle Scholar
  20. 20.
    Gimenez-Roqueplo A, Dahia P, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res. 2012;44:328–33.CrossRefGoogle Scholar
  21. 21.
    Scholz T, Eisenhofer G, Pacak K, et al. Clinical review: current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab. 2007;92:1217–25.CrossRefGoogle Scholar
  22. 22.
    Galan R, Kann H. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma. Clin Endocrinol. 2013;78:165–75.CrossRefGoogle Scholar
  23. 23.
    Pacak K, Eisenhofer G, Ahlman H, et al. International symposium on pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab. 2007;3:92102.Google Scholar
  24. 24.
    Eisenhofer G, Goldstein DS, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true from false positive test results. J Clin Endocrinol Metab. 2003;88:2656–66.CrossRefGoogle Scholar
  25. 25.
    Goldstein DS, Eisenhofer G, Flynn JA, Wand G, Pacak K. Diagnosis and localization of pheochromocytoma. Hypertension. 2004;43:90710.Google Scholar
  26. 26.
    Agrawal R, Mishra SK, Bhatia E, Mishra A, Chand G, Agarwal G, Agarwal A, Verma AK. Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin. World J Surg. 2014;38(3):716–23.CrossRefGoogle Scholar
  27. 27.
    Agarwal A, Mehrotra PK, Jain M, Gupta SK, Mishra A, Chand G, Agarwal G, Verma AK, Mishra SK, Singh U. Size of the tumour and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS): can they predict malignancy? World J Surg. 2010;34(12):3022–8.CrossRefGoogle Scholar
  28. 28.
    Bhargava PR, Mishra A, Agarwal G, Agarwal A, Verma AK, Mishra SK. Adrenal incidentalomas: experience from a developing country. World J Surg. 2008;32(8):1802–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2018

Authors and Affiliations

  • Anand Kumar Mishra
    • 1
  • Kulranjan Singh
    • 1
  • Pooja Ramakant
    • 1
  • Amit Agarwal
    • 2
  1. 1.Department of Endocrine SurgeryKing George’s Medical UniversityLucknowIndia
  2. 2.Department of Endocrine SurgerySanjay Gandhi Post Graduate Institute of Medical SciencesLucknowIndia

Personalised recommendations